Nutex Health (NUTX) Revenue (2010 - 2026)

Nutex Health has disclosed Revenue across 17 years of filings, most recently posting $216.5 million for Q1 2026.

• Revenue for Q1 2026 came in at $216.5 million, up 2.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $880.0 million (up 40.95% YoY), and the FY2025 annual result was $875.3 million, up 82.36% from the prior year.
• Revenue came in at $216.5 million for Q1 2026 at Nutex Health, up from $151.7 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $267.8 million in Q3 2025 to a low of $28.4 million in Q3 2022.
• The 5-year median for Revenue is $76.1 million (2024), against an average of $119.9 million.
• Peak annual rise in Revenue reached 3828.19% in 2022, while the deepest fall reached 75.93% in 2022.
• Nutex Health's Revenue stood at $53.7 million in 2022, then grew by 29.68% to $69.7 million in 2023, then soared by 269.77% to $257.6 million in 2024, then tumbled by 41.12% to $151.7 million in 2025, then jumped by 42.73% to $216.5 million in 2026.
• The last three Revenue figures came in at $216.5 million (Q1 2026), $151.7 million (Q4 2025), and $267.8 million (Q3 2025), per Business Quant data.